Goldman Sachs Adjusts Price Target on Willis Towers Watson to $361 From $385, Keeps Buy Rating
Goldman Sachs reduced its price target for Willis Towers Watson from $385 to $361 but maintained a buy rating. The company recently acquired Al-Futtaim's 51% stake in a UAE joint venture. Willis Towers Watson's stock has seen a 12.29% decline over the past year.
How this was made
The 30-second read
Why it matters
The downgrade may trigger short‑term selling but the Buy rating tempers the impact.
Market read
A fresh analyst target cut for a large U.S. insurer, offering a short‑term trading cue.
What to watch
Potential upcoming earnings or client wins could offset the target cut.
Background
Goldman Sachs routinely updates its coverage; this is the latest price‑target revision for WTW.
Ticker impact
Goldman Sachs lowered its price target for Willis Towers Watson to $361 from $385 and kept a Buy rating.
likely pressure as the market prices in the lower target
Target reduction is a fresh analyst downgrade, which typically prompts short‑term selling pressure.
Market effects
Minimal; the change reflects a firm‑specific valuation adjustment rather than a sector trend.
U.S. market focus; no broader regional effect.
Limited to investors tracking Willis Towers Watson.
Counterpoint
Some investors may view the unchanged Buy rating as a sign of confidence despite the lower target.
Key entities
- AnalystGoldman Sachs
Equity research firm providing the price‑target revision.
- CompanyWillis Towers Watson
Global advisory, brokering and solutions company.




